CD1C and carcinoma of esophagus: In line with the defective quantification of DCs in esophageal carcinoma, FACS results in the present study displayed that the percentages of CD1c+ mDCs, and CD141+ mDCs among PBMCs in ESCC patients were significantly lower than healthy controls.